Immunoblastic Lymphadenopathy

This is a specific type of enlarged lymph node (a part of your immune system). It happens when the cells inside the lymph node grow abnormally. This can cause symptoms like fever, night sweats, and weight loss, and often makes lymph nodes larger all over your body.

Condition

What people with Immunoblastic Lymphadenopathy report

Every report comes from a Lived member, sent anonymously.

Have you tried Combination Chemotherapy for Immunoblastic Lymphadenopathy?

NameHow it went

About Immunoblastic Lymphadenopathy

What It Is

Immunoblastic lymphadenopathy, also called angioimmunoblastic lymphadenopathy or AILD, is an older name for a disorder in which lymph nodes throughout the body enlarge while the immune system becomes overactive and disordered. When it was first described in the 1970s, doctors thought it was an exaggerated immune reaction rather than a cancer. Later research showed that it is driven by a single abnormal family of immune cells, and it is now recognized as angioimmunoblastic T-cell lymphoma (AITL), a type of non-Hodgkin lymphoma. Its newest official name is nodal T-follicular helper cell lymphoma, angioimmunoblastic type. The abnormal cells are a kind of T cell (a white blood cell) that normally helps B cells make antibodies. When these cells multiply out of control, they stir up the surrounding immune system. That explains why the illness often looks like a widespread inflammatory or autoimmune disease: swollen glands in several places, fever, drenching night sweats, weight loss, itchy rash, and an enlarged liver or spleen. Blood tests may show high antibody levels, anemia from the immune system destroying red blood cells, or a positive autoimmune test. AITL is uncommon, accounting for about 1 to 2% of non-Hodgkin lymphomas, and it mostly affects people in their 60s and older. Most people already have widespread disease when it is found.

Causes & Risk Factors

The cause is not fully understood, and nothing a person did is known to bring it on. The disease appears to develop in steps. With age, blood-forming stem cells can pick up genetic changes, most often in genes that control how other genes are switched on and off, that let one group of cells expand without causing illness. Additional changes in the helper T cells descended from them can then turn that group into a lymphoma. This age-related process helps explain why AITL is mainly a disease of older adults and is more common in men. Epstein-Barr virus, the common virus that causes mononucleosis, is found in most AITL lymph nodes. It mainly infects the surrounding B cells rather than the cancer cells, and it is seen as part of the disordered immune picture rather than a proven cause.

How It's Diagnosed

Because the symptoms resemble infections, autoimmune diseases and other lymphomas, AITL is often hard to recognize at first, and diagnosis can take time. The essential test is a biopsy, ideally removal of a whole enlarged lymph node, since a small needle sample or a skin biopsy often does not show enough of the node's structure. A pathologist looks for the disease's typical pattern, including branching small blood vessels and a mix of immune cells, and uses special stains to show that the abnormal T cells carry helper T-cell markers. Tests for Epstein-Barr virus and for the gene changes typical of AITL can support the diagnosis, and a test showing that the T cells all come from one clone helps separate lymphoma from a reactive immune response. Once lymphoma is confirmed, staging shows how far it has spread. This usually includes a PET scan combined with computed tomography (a detailed X-ray scan), using a tracer that highlights active disease, a bone marrow biopsy (the marrow is involved in a large share of cases), and blood tests of blood counts, organ function and LDH (lactate dehydrogenase, an enzyme that tends to rise when lymphoma is active). These results feed into risk scores that help estimate outlook and guide treatment intensity.

Treatment Options

AITL is treated by a hematologist or oncologist, ideally at a center experienced in T-cell lymphomas. Because no treatment approach works well enough for most people, expert guidelines list joining a clinical trial as a preferred option at every stage. For people fit enough, first treatment is usually combination chemotherapy given in cycles over several months. The most common regimen is CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone, a steroid), sometimes with a fifth drug, etoposide, added for younger patients. Many people respond at first, but the disease often returns. For people who respond well, doctors may recommend an autologous stem cell transplant: very high-dose chemotherapy followed by a return of the person's own previously collected blood stem cells. Some studies suggest this keeps the lymphoma away longer, but the evidence is mixed and it is demanding, so it is usually offered only to fitter, often younger patients. Older or frailer people may receive gentler treatment, since doxorubicin-containing chemotherapy can be too much for people with other health problems or limited strength. When AITL returns or does not respond, options include different chemotherapy, a donor (allogeneic) stem cell transplant for selected people, and newer targeted drugs. Medicines that change how genes inside the lymphoma cells are switched on and off have shown relatively good response rates in AITL, but responses are often temporary. Supportive care also matters, including treatment for anemia, other immune complications and infections.

What to Expect

AITL is a serious lymphoma, and its course varies widely. For many people it behaves aggressively, and even after a good first response it frequently comes back within a few years. A smaller group has slower disease and lives for many years. Risk scores based on age, general fitness, blood test results and how far the lymphoma has spread give a rough picture of outlook, but they cannot predict any one person's course. Treatment brings its own demands. Chemotherapy cycles usually mean regular clinic visits, blood tests and tiredness that builds over the course of treatment, and a transplant can take months of recovery. Because both the lymphoma and its treatment weaken the immune system, infections are a real concern throughout, and care teams often recommend steps such as careful hand washing and food safety. After treatment ends, follow-up visits, blood tests and sometimes scans watch for the lymphoma returning. Many people find it useful to talk early with their team about goals of care, support for caregivers, and what a second line of treatment would look like.

When to Seek Help

See a clinician if lymph nodes stay swollen for more than a few weeks without an obvious cause, especially with unexplained fevers, drenching night sweats, weight loss, or a persistent rash. Most swollen glands turn out to be harmless, but this pattern deserves assessment. If you have AITL, tell your care team promptly about new or growing lymph nodes, worsening fatigue or breathlessness, yellowing skin, unusual bruising or bleeding, or symptoms returning after treatment. During treatment, call your care team right away for a fever of 100.5°F (38°C) or higher, shaking chills, or other signs of infection, because infections when white blood cell counts are low can become life threatening quickly. Ask in advance how to reach the team after hours, and check with them before taking medicine to bring a fever down, since it can hide a serious infection.

Questions to Ask Your Doctor

  1. 1.What do the biopsy results show, and has an expert in lymphoma pathology confirmed the diagnosis?
  2. 2.What is the stage and risk score of my lymphoma, and what does that mean for my treatment options?
  3. 3.Is there a clinical trial I could join, and how would it compare with standard chemotherapy for me?
  4. 4.Would a stem cell transplant make sense for me after first treatment, and what would it involve?
  5. 5.How can I lower my risk of infection during treatment, and when should I call you?

Last reviewed • Oct 2026

Educational content, not medical advice.